Product Information
HAILEY 21 1.5 MG-30 MCG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3358 per EA under NDC 68462050481. Its NADAC has been published 369 times since Sep 11, 2019.
FDA first approved this application on Jun 5, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.03; 1.5 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462050481
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA209297FDA Approved
6/5/2018
TE Code
AB
On Market Since
6/5/2018
Price Statistics
The NADAC for HAILEY 21 1.5 MG-30 MCG TAB has been published 369 times since Sep 11, 2019, and over the history we have for it it has declined 45.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3358 per EA |
|---|---|
| All-time high | $0.6816 (Apr 15, 2020) |
| All-time low | $0.3066 (Jul 17, 2024) |
| 52-week high | $0.3923 |
| 52-week low | $0.3344 |
| Median price | $0.5212 |
| Average price | $0.4931 |
| Largest weekly change | +67.3% (Aug 21, 2024) |
| Weeks tracked | 369 |
| Tracking since | Sep 11, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Norethindrone Acetate and Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HAILEY 21 1.5 MG-30 MCG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HAILEY 21 1.5 MG-30 MCG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3358 per EA (NDC 68462050481), effective Sep 30, 2026.
How has the price of HAILEY 21 1.5 MG-30 MCG TAB changed over time?
Over the history we have for it, the NADAC for HAILEY 21 1.5 MG-30 MCG TAB has declined 45.7%. It has been tracked across 369 weekly CMS publications since Sep 11, 2019.
What are the highest and lowest recorded NADAC prices for HAILEY 21 1.5 MG-30 MCG TAB?
Since Sep 11, 2019, the NADAC for HAILEY 21 1.5 MG-30 MCG TAB has ranged from a low of $0.3066 (Jul 17, 2024) to a high of $0.6816 (Apr 15, 2020), with a median of $0.5212 per EA.
Are there cheaper alternatives to HAILEY 21 1.5 MG-30 MCG TAB?
No other NADAC-published product currently shares the active ingredient and strength of HAILEY 21 1.5 MG-30 MCG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HAILEY 21 1.5 MG-30 MCG TAB?
HAILEY 21 1.5 MG-30 MCG TAB (NDC 68462050481) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.